Radmila A. Filippova

Radmila A. Filippova

Auto-generated profile, based on publicly available information

Radmila A. Filippova

Sechenov Institute of Evolutionary Physiology and Biochemistry of the Russian Academy of Sciences Saint Petersburg Russia

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 August 2026 in European Journal of Neuroscience
Verified
Journal Article
Closed access
AIAndrey P. Ivlev
Andrey P. Ivlev
RFRadmila A. Filippova
Radmila A. Filippova
YGYulia S. Grigorieva
Yulia S. Grigorieva
LNLiubov S. Nikitina
Liubov S. Nikitina
MGMargarita Glazova
Margarita Glazova
ECElena Chernigovskaya
Elena Chernigovskaya

6 September 2026 in SSRN Electronic Journal
Verified
Preprint
Open access
ANAlexandra A. Naumova
Alexandra A. Naumova
OAOlga S. Alekseeva
Olga S. Alekseeva
OCOxana V. Chistyakova
Oxana V. Chistyakova
DVDmitriy S. Vasilev
Dmitriy S. Vasilev
AKAlexey A. Kulikov
Alexey A. Kulikov
DTDenis B. Tikhonov
Denis B. Tikhonov
Recent studies have revealed that antiepileptic drug phenytoin (PHT) inhibits not only voltage-gated sodium channels (VGSCs), but also α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors (AMPARs), particularly calcium-impermeable (CI) ones. However, the benefit of this additional action for seizure control has not been fully understood. Here, we used three experimental seizure models to compare the efficacy of PHT and PHT derivatives, which showed different profiles of activity against VGSC/CI-AMPAR in the recent in vitro studies. Among tested compounds, we selected Hyd-8 (diphenylthiohydantoin), active against both targets with enhanced activity against CI-AMPARs, Hyd-5, acting only on VGSCs, and Hyd-1, inactive against both. The compounds were administered intraperitoneally to Wistar rats, further exposed to pentylenetetrazole (PTZ) and hyperbaric oxygen (HBO2) seizures, and to Krushinsky-Molodkina (KM) audiogenic rats before the further audiogenic seizure stimulations. Behavioral side effects were assessed after the drug injections and seizure stimulations by means of the open field test (OFT). In the HBO2 model, all PHT-related compounds were ineffective and shortened seizure latency. In PTZ and audiogenic seizure models, Hyd-5 and Hyd-8 showed anticonvulsant activity, with Hyd-8 generally demonstrating more beneficial profile. OFT showed that PHT derivatives did not share the behavior-suppressing effect of PHT, although Hyd-8 induced agitation in KM rats, likely reflecting strain-specific behavior. These results suggest that Hyd-8 is a promising antiseizure candidate, whereas seizures triggered by oxidative stress require alternative therapeutic strategies.

19 July 2025 in Brain Research
Verified
Journal Article
Closed access
AIAndrey P. Ivlev
Andrey P. Ivlev
RFRadmila A. Filippova
Radmila A. Filippova
EAEkaterina P. Aleksandrova
Ekaterina P. Aleksandrova
AKAlexey A. Kulikov
Alexey A. Kulikov
ANAlexandra A. Naumova
Alexandra A. Naumova
ECElena Chernigovskaya
Elena Chernigovskaya